BTAI vs HAS · rev $388.0K vs P/E 25, rev $2.40B
BioXcel Therapeutics Inc (BTAI) versus Hasbro Inc (HAS) — a side-by-side from cached financials, not a winner call.
BioXcel Therapeutics Inc (BTAI) is a drug manufacturers - specialty & generic company listed on US.
Hasbro Inc (HAS) is a leisure company listed on US.
Latest reported BTAI revenue for 2026-06-30 was $388.0K. Net income was -$27.4M. Revenue was up 88.3% from 2026-03-31 to 2026-06-30. BTAI currently screens at market cap $36.1M.
Latest reported HAS revenue for 2026-06-28 was $2.40B. Net income was $359.3M. HAS currently screens at market cap $10.75B and trailing P/E 25.3.
BTAI currently screens at market cap $36.1M. HAS currently screens at market cap $10.75B and trailing P/E 25.3.
Not investment advice. Open the BTAI and HAS stock pages for the full models.
Not investment advice.